XBI

State Street® SPDR® S&P® Biotech…

• Benzinga·14h ago

  Citigroup, Morgan Stanley, CBRE Group And More On CNBC's 'Final Trades'

• The Wall Street Journal·1d ago

  Big Pharma Is Thinking Small on Deals. That's a Boon for Biotech. -- Heard on the Street

• Seeking Alpha·2d ago

  Global PMI: Tracking The Sectors Hit Hardest By The Middle East War

• Seeking Alpha·3d ago

  Can Forgotten Biotech Break Out?

• Seeking Alpha·04/07 06:35

  Quant check on insurer stocks as Medicare Advantage rate boost drives gains

• Benzinga·04/06 12:13

  Neurocrine Buys Soleno To Tap High-Growth Rare Disease Market

• Seeking Alpha·04/02 16:49

  Biotech Is Holding Steady In 2026

• TipRanks·04/02 15:21

  IBB, IHI, XBI: Boost Your Portfolio with Healthcare Exchange-Traded Funds (ETFs)

• Benzinga·04/02 14:00

  $1000 Invested In State Street SPDR S&P Biotech ETF 20 Years Ago Would Be Worth This Much Today

• Seeking Alpha·04/02 05:01

  No deal yet? Trump readies 100% tariffs on select drugmakers - report

• NASDAQ·03/30 14:49

  XBI, IBRX, TGTX, APGE: Large Outflows Detected at ETF

• TipRanks·03/27 13:40

  Unusually active option classes on open March 27th

• NASDAQ·03/25 10:20

  Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?

• NASDAQ·03/17 14:54

  XBI, MRNA, ROIV, ACLX: Large Outflows Detected at ETF

• Seeking Alpha·03/17 14:20

  Geopolitically Themed Investment Risks And Opportunities Take Center Stage